Ardelyx, Inc. (NASDAQ:ARDX)
Industry: Biotechnology

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

Current Quote*
Last: $4.270
Change: 0.000
Book: $1.321
Volume: 2,835,350

As Of: 07/03 16:12 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol ARDX

Graphs for ARDX


3 Month Graph


6 Month Graph


1 Year Graph